A high triglyceride to high-density lipoprotein cholesterol ratio is associated with poor renal outcome in IgA nephropathy patients

Background: Dyslipidemia is common in patients with chronic kidney disease. However, whether markers of atherogenic dyslipidaemia correlate with outcomes in IgA nephropathy (IgAN) patients as in the general population is uncertain. The aim of this study was to explore the prognostic value of the serum triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio to predict ESRD in IgAN patients.Methods: A total of 1149 patients from West China Hospital of Sichuan University were retrospectively analysed between 2008 and 2018, with a median follow-up of 54.0 months. The demographic, clinical and pathological data of all patients at the time of biopsy were collected. Receiver operating curve (ROC) was used to determine the optimal threshold for the TG/HDL ratio at baseline to predict ESRD during follow-up. Prognostic values were assessed by univariate and multivariate Cox regression analyses and Kaplan–Meier curves.Results: The optimal cut-off value for the TG/HDL-C ratio was 1.495. The correlation analysis showed that the TG/HDL-C ratio was negatively correlated with the eGFR (r = 0.248, P < 0.001) but positively correlated with proteinuria (r = 0.229, P< 0.001) and serum uric (r =0.306, P< 0.001). Patients with a higher TG/HDL-C ratio tended to have hypertension [odds ratio (OR), 1.702; 95% CI, 1.298-2.233; P<0.001] and more severe pathologic lesions with tubular atrophy/interstitial fibrosis (OR, 3.593; 95% CI, 2.528-5.107; P<0.001). A high TG/HDL ratio was strongly correlated with worse renal survival in IgAN patients (log-rank: P <0.001). Multivariate Cox analysis demonstrated that an elevated TG/HDL-C ratio (HR 2.118, 95% CI 1.333-3.367, P=0.002) was an independent risk marker to predict ESRD.Conclusion: The TG/HDL-C ratio may serve as potential prognostic biomarkers in IgAN patients.

[1]  P. López-Jaramillo,et al.  Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary , 2021, Hypertension.

[2]  Xiaoqiang Ding,et al.  The effect of triglycerides to high-density lipoprotein cholesterol ratio on the reduction of renal function: findings from China health and retirement longitudinal study (CHARLS) , 2021, Lipids in Health and Disease.

[3]  Lingqiu Dong,et al.  High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy , 2021, Frontiers in Immunology.

[4]  J. J. Lozano-Nuevo,et al.  High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients , 2021, Clinical Nutrition ESPEN.

[5]  S. Bakker,et al.  The triglyceride to HDL-cholesterol ratio and chronic graft failure in renal transplantation. , 2021, Journal of clinical lipidology.

[6]  Y. Kim,et al.  Predictive value of triglyceride/high-density lipoprotein cholesterol for major clinical outcomes in advanced chronic kidney disease: a nationwide population-based study , 2020, Clinical kidney journal.

[7]  E. Bonora,et al.  Independent association of atherogenic dyslipidaemia with all‐cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study , 2020, Cardiovascular Diabetology.

[8]  D. Kyriaki,et al.  Triglycerides to High-Density Lipoprotein Cholesterol Ratio Predicts Chronic Renal Disease in Patients without Diabetes Mellitus (STELLA Study) , 2020, Journal of cardiovascular development and disease.

[9]  H. Zou,et al.  Association of Lipid Parameters with the Risk of Chronic Kidney Disease: A Longitudinal Study Based on Populations in Southern China , 2020, Diabetes, metabolic syndrome and obesity : targets and therapy.

[10]  Andrew M. Wilson,et al.  Elevated Triglycerides to High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio Predicts Long-Term Mortality in High-Risk Patients. , 2020, Heart, lung & circulation.

[11]  G. Hu,et al.  Nonlinear relationship between triglyceride/high-density lipoprotein cholesterol ratio and chronic kidney disease in US adults: a National Health and Nutrition Examination Survey investigation , 2019, International Urology and Nephrology.

[12]  Ž. Reiner Hypertriglyceridaemia and risk of coronary artery disease , 2017, Nature Reviews Cardiology.

[13]  L. Juillard,et al.  Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins , 2016, Toxins.

[14]  Y. Ohashi,et al.  Impact of the Triglycerides to High-Density Lipoprotein Cholesterol Ratio on the Incidence and Progression of CKD: A Longitudinal Study in a Large Japanese Population. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  Y. Weng,et al.  Relationship between TG/HDL-C ratio and metabolic syndrome risk factors with chronic kidney disease in healthy adult population. , 2015, Clinical nutrition.

[16]  S. Devaraj,et al.  Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. , 2014, The Journal of clinical endocrinology and metabolism.

[17]  C. Schmid,et al.  Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. , 2011, Kidney international.

[18]  C. Cohen,et al.  Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids. , 2010, American journal of physiology. Renal physiology.

[19]  N. Vaziri Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. , 2006, American journal of physiology. Renal physiology.

[20]  P. Zucchelli,et al.  [IgA nephropathy]. , 1985, Medicina clinica.